Clinical trials
Phase 3 Heart Failure trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 11 |
| Terminated | 9 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| AstraZeneca | 4 |
| Novo Nordisk A/S | 3 |
| Amgen | 2 |
| Cytokinetics | 2 |
| Lexicon Pharmaceuticals | 2 |
| LivaNova | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| Alnylam Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 53 |
| Cardiovascular Diseases | 5 |
| Heart Diseases | 3 |
| Hypertension | 3 |
| Stroke | 3 |
| Acute Coronary Syndrome | 2 |
| Cardiomyopathies | 2 |
| Coronary Artery Disease | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyspnea | 2 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.